ImmunityBio: Q4 Earnings Insights

ImmunityBio IBRX reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:31 PM.

Here's what investors need to know about the announcement.

Earnings

ImmunityBio missed estimated earnings by -111.00000000000001%, reporting an EPS of $-0.38 versus an estimate of $-0.18.

Revenue was up $66 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 9.0% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for ImmunityBio visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.